Ppe Net - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
PP&E Net Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
PP&E Net
zł75.8m
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
PP&E Net
zł660k
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
-14%
M
Medicofarma Biotech SA
WSE:MDB
PP&E Net
zł12.6m
CAGR 3-Years
N/A
CAGR 5-Years
191%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
PP&E Net
zł318.2m
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's PP&E Net?
PP&E Net
75.8m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's PP&E Net amounts to 75.8m PLN.

What is Ryvu Therapeutics SA's PP&E Net growth rate?
PP&E Net CAGR 5Y
0%

Over the last year, the PP&E Net growth was -5%. The average annual PP&E Net growth rates for Ryvu Therapeutics SA have been -6% over the past three years .

Back to Top